ArticleCVIR endovascular2026
Deployment of aortoiliac balloon-expandable covered stent via the transradial approach: report of two cases.
Article in CVIR endovascular, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndovascular therapy (EVT) for aortoiliac (AI) disease has shown favorable outcomes with recent advances in technology. Furthermore, the transradial approach (TRA) has emerged as a less invasive alternative to transfemoral access, improving patient comfort. However, data on CS implantation using the TRA remain limited. CASE PRESENTATION: We report two cases in which a VIABAHN® VBX-CS (W.L. Gore & Associates, Flagstaff, AZ, USA) were successfully deployed for AI disease using the TRA. In both cases, a 6-Fr transradial guiding sheath was used. The CSs were advanced and accurately deployed using a TRA without complications. The completion of the angiography confirmed the proper expansion and positioning of the CS. Both patients were discharged uneventfully without access-site complications. DISCUSSION: These cases demonstrate the feasibility and safety of AI balloon-expandable CS implantation using the TRA. The evolution of the device has enabled the delivery of relatively large CS using the TRA, expanding the applicability of this less invasive technique.
conclusionTransradial CS treatment may be a promising procedure for AI lesions, offering both procedural safety and patient comfort.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.